Sigrid Stroobants
Impact in
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
Papers in
-
- Medical Imaging Techniques and Applications 118
- Radiomics and Machine Learning in Medical Imaging 34
- Advanced MRI Techniques and Applications 29
- Radiopharmaceutical Chemistry and Applications 20
-
- Lung Cancer Diagnosis and Treatment 35
- Lung Cancer Treatments and Mutations 31
- Co-authors
- Patrick DupontJohan VansteenkisteLuc MortelmansMalik E. JuweidSteven StaelensKaroline SpaepenJohan NuytsLena Specht
- Journals
- Journal of Clinical Oncology (16 papers)Journal of Nuclear Medicine (15 papers)European Journal of Nuclear Medicine and Molecular Imaging (13 papers)Molecular Imaging and Biology (11 papers)European Journal of Cancer (7 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Sigrid Stroobants
242 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Gastroenterology 1.6k
- Radiology, Nuclear Medicine and Imaging 6.5k
- Pathology and Forensic Medicine 4.8k
- Pulmonary and Respiratory Medicine 6.4k
- Neurology 2.1k
Countries citing papers authored by Sigrid Stroobants
This map shows the geographic impact of Sigrid Stroobants's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigrid Stroobants with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigrid Stroobants more than expected).
Fields of papers citing papers by Sigrid Stroobants
This network shows the impact of papers produced by Sigrid Stroobants. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigrid Stroobants. The network helps show where Sigrid Stroobants may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sigrid Stroobants, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 20 | |
| 8 | 2018 | 4 | |
| 9 | 2017 | 17 | |
| 10 | 2014 | 31 | |
| 11 | EARL FDG-PET/CT accreditation program: Feasibility, overview and results of first 55 successfully accredited sites | 2013 | 15 |
| 12 | 2010 | 28 | |
| 13 | Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma Hit paper breakdown → | 2007 | 967 |
| 14 | Hodgkin's lymphoma: Response assessment by revised international workshop criteria | 2007 | 1 |
| 15 | Reflections on the current staging system for lung cancer | 2002 | 1 |
| 16 | Early restaging positron emmision tomography (PET) with 18F-fluorodeoxyglucose ((18)FDG) predicts outcome in patients with aggressive non Hodgkin's lymphoma (NHL). | 2001 | 3 |
| 17 | Clinical relevance of whole body FDG-PET (WB-PET) in recurrent malignant melanoma | 1999 | 1 |
| 18 | Role of 18F-2-deoxyglucose positron emission tomography (FDG-PET) after induction chemotherapy In stage IIIA-N2 non-small cell lung cancer (N2-NSCLC) | 1998 | 3 |
| 19 | Lymph node mapping in non-small cell lung cancer with FDG-PET scan: a prospective study in 690 LN levels from 68 patients | 1997 | 3 |
| 20 | Comparison of whole-body positron emission tomography and Gallium-67 citrate imaging for staging of lymphoma | 1996 | 2 |
About Sigrid Stroobants
Sigrid Stroobants is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Biological Psychiatry, Pathology and Forensic Medicine and Gastroenterology, having authored 250 papers that have together received 15.9k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (118 papers), Lung Cancer Diagnosis and Treatment (35 papers), Radiomics and Machine Learning in Medical Imaging (34 papers), Lung Cancer Treatments and Mutations (31 papers), Lymphoma Diagnosis and Treatment (29 papers), Advanced MRI Techniques and Applications (29 papers), Radiopharmaceutical Chemistry and Applications (20 papers) and Cancer, Hypoxia, and Metabolism (14 papers). The work is most often cited by research in Gastroenterology (1.6k citations), Radiology, Nuclear Medicine and Imaging (6.5k citations), Pathology and Forensic Medicine (4.8k citations), Pulmonary and Respiratory Medicine (6.4k citations) and Neurology (2.1k citations). Sigrid Stroobants has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Patrick Dupont, Johan Vansteenkiste, Luc Mortelmans, Malik E. Juweid, Steven Staelens, Karoline Spaepen, Luc Mortelmans, Johan Nuyts, Lena Specht and Randy D. Gascoyne. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Molecular Imaging and Biology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.